These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34584248)

  • 1. A public-private partnership model for COVID-19 diagnostics.
    Krijger PHL; Hoek TA; Boersma S; Donders LIPM; Broeders MMC; Pieterse M; Toonen PW; Logister I; Verhagen BMP; Verstegen MJAM; van Ravesteyn TW; Roymans RJTM; Mattiroli F; Vandesompele J; Nijhuis M; Meijer S; van Weert A; Dekker E; Dom FJ; Ruijtenbeek R; van der Velden LBJ; van de Bovenkamp JHB; Bosch M; de Laat W; Tanenbaum ME
    Nat Biotechnol; 2021 Oct; 39(10):1182-1184. PubMed ID: 34584248
    [No Abstract]   [Full Text] [Related]  

  • 2. Public-Private-People Partnerships (4P) for Improving the Response to COVID-19 in Iran.
    Seddighi H; Seddighi S; Salmani I; Sharifi Sedeh M
    Disaster Med Public Health Prep; 2021 Feb; 15(1):e44-e49. PubMed ID: 32576337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19: Opportunity to Re-Imagine Our Response to a National Medical Crisis.
    Remick KN; Carr BG; Elster E
    J Am Coll Surg; 2021 May; 232(5):793-796. PubMed ID: 33592250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The untimely demise of the TB Free block model in the wake of coronavirus disease 2019 in India.
    Datta B; Jaiswal A; Goyal P; Prakash A; Tripathy JP; Trehan N
    Trans R Soc Trop Med Hyg; 2020 Nov; 114(11):789-791. PubMed ID: 32797204
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System.
    Weitzman ER; Sherman AC; Levy O
    Front Public Health; 2021; 9():695807. PubMed ID: 34336774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak.
    Binnicker MJ
    Clin Chem; 2020 May; 66(5):664-666. PubMed ID: 32077933
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 pandemic and some observations about management of breast cancer at private practice.
    Altundag K
    J BUON; 2020; 25(5):2530. PubMed ID: 33277884
    [No Abstract]   [Full Text] [Related]  

  • 8. The accountability of the private sector towards citizens in times of crisis: vaccines, medicines and equipment.
    Petelos E; Lingri D; Ghattas J; Evers SMAA; Paget DZ; de Waure C
    Eur J Public Health; 2021 Nov; 31(Supplement_4):iv54-iv58. PubMed ID: 34751360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy to guarantee oncological surgical care during the COVID-19: the public and private healthcare partnership.
    Giordano A; Forasassi L; Galli S
    Minerva Surg; 2021 Apr; 76(2):195-196. PubMed ID: 33179467
    [No Abstract]   [Full Text] [Related]  

  • 10. India's crusade against COVID-19.
    Madkaikar M; Gupta N; Yadav RM; Bargir UA
    Nat Immunol; 2021 Mar; 22(3):258-259. PubMed ID: 33627877
    [No Abstract]   [Full Text] [Related]  

  • 11. The COVID-19 pandemic: the third wave?
    Ashton J
    J R Soc Med; 2021 Jul; 114(7):367-368. PubMed ID: 34250864
    [No Abstract]   [Full Text] [Related]  

  • 12. Public opinion on global rollout of COVID-19 vaccines.
    Clarke PM; Roope LSJ; Loewen PJ; Bonnefon JF; Melegaro A; Friedman J; Violato M; Barnett A; Duch R
    Nat Med; 2021 Jun; 27(6):935-936. PubMed ID: 33785911
    [No Abstract]   [Full Text] [Related]  

  • 13. Meeting the challenge of long COVID.
    Nat Med; 2020 Dec; 26(12):1803. PubMed ID: 33288947
    [No Abstract]   [Full Text] [Related]  

  • 14. The Yin and Yang of SARS-CoV-2 Mutation and Evolution.
    Badley AD
    Mayo Clin Proc; 2021 Apr; 96(4):863-865. PubMed ID: 33715846
    [No Abstract]   [Full Text] [Related]  

  • 15. Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries.
    Haldane V; De Foo C; Abdalla SM; Jung AS; Tan M; Wu S; Chua A; Verma M; Shrestha P; Singh S; Perez T; Tan SM; Bartos M; Mabuchi S; Bonk M; McNab C; Werner GK; Panjabi R; Nordström A; Legido-Quigley H
    Nat Med; 2021 Jun; 27(6):964-980. PubMed ID: 34002090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutations, variants and strains of SARS-CoV-2].
    Gamero-de-Luna EJ; Gamero-Estévez E
    Semergen; 2021 Apr; 47(3):208-209. PubMed ID: 33593674
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of the COVID-19 Pandemic in the Republic of Korea from the Perspective of Governance and Public-Private Partnership.
    Kim W; Jung TY; Roth S; Um W; Kim C
    Yonsei Med J; 2021 Sep; 62(9):777-791. PubMed ID: 34427063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming Brazil's monumental COVID-19 failure: an urgent call to action.
    Hallal PC; Victora CG
    Nat Med; 2021 Jun; 27(6):933. PubMed ID: 33958796
    [No Abstract]   [Full Text] [Related]  

  • 19. Partnership between the academy and public and private health systems to fight COVID-19: an experience report in Tubarão, Santa Catarina, Brazil.
    Schuelter-Trevisol F; Iser BPM; Marcon CEM; Mello RS; Souza KM; Baldessar MZ; Trevisol DJ
    Epidemiol Serv Saude; 2020 Sep; 29(4):e2020499. PubMed ID: 32901699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steering the Private Sector in COVID-19 Diagnostic Test Kit Development in South Korea.
    Lee S
    Front Public Health; 2020; 8():563525. PubMed ID: 33282810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.